Schweiz UNESCO

Schweizer Parlamentarier protestieren gegen israelfeindliche UNESCO-Resolutionen http://www.audiatur-online.ch/2016/11/03/schweizer-parlamentarier-protestieren-gegen-israelfeindliche-unesco-resolutionen/

UNESCO schockierend

Internationale Parlamentarier in Hebron: Entscheidung der UNESCO ist „schockierend“ http://www.audiatur-online.ch/2016/10/20/internationale-parlamentarier-in-hebron-entscheidung-der-unesco-ist-schockierend/

UNESCO antisemitism

Die Unesco und das Weltkulturerbe Antisemitismus http://www.audiatur-online.ch/2016/10/18/die-unesco-und-das-weltkulturerbe-antisemitismus/

Innovative boat

Technion Researchers Develop Innovative Boat http://www.technion.ac.il/en/2016/10/technion-researchers-develop-innovative-boat/

Arizona law review

http://arizonalawreview.org/palestine-uti-possidetis-juris-and-the-borders-of-israel/

United anti

The UN and Israel: Key Statistics from UN Watch http://www.unwatch.org/un-israel-key-statistics/

Olympische spiele

Olympische Spiele – Der Skandal als Normalität http://www.audiatur-online.ch/2016/08/10/olympische-spiele-der-skandal-als-normalitaet/

Rechtsgryndlagen

Israel – Rechtsgrundlagen und Geschichte http://www.audiatur-online.ch/2016/07/07/israel-rechtsgrundlagen-und-geschichte/

Molecular electronics

On the Way to Molecular Electronics http://www.technion.ac.il/en/2016/07/on-the-way-to-molecular-electronics/

Bill Gates

Bill Gates among investors in new Israeli tech incubator http://www.jpost.com/Business-and-Innovation/Tech/Bill-Gates-among-investors-in-new-Israeli-tech-incubator-457336

Nano targets

Nanomedicine Targets Gastric Tumors http://www.technion.ac.il/en/2016/06/nanomedicine-targets-gastric-tumors/

Startup finance

Meet the Startups Transforming the World of Finance [Infographic] http://blog.ourcrowd.com/meet-the-startups-transforming-the-world-of-finance/

Amnesty & Propaganda

Amnesty International missbraucht Judenverfolgung für politische Propaganda http://www.audiatur-online.ch/2016/06/08/amnesty-international-missbraucht-judenverfolgung-fuer-politische-propaganda/

Schweiz bezahlt

http://verlag.baz.ch/artikel/?objectid=1744F86D-5D4E-41D5-8E5969A2CDBDAD3E#.V0S5b8zhWKE.twitter

Linkenhass

Der Hass der Linken auf Israel und seine sowjetischen Wurzeln http://www.audiatur-online.ch/2016/05/23/der-hass-der-linken-auf-israel-und-seine-sowjetischen-wurzeln/

Geofun

Geofun, the center for desert biking, Sde Boker, Israel http://www.israelbiketrails.com/ServiceProviders/Geofun/tabid/63/Default.aspx Shared from PeanutBrowser.com.

Kranz

http://www.audiatur-online.ch/2016/05/04/schweizer-parlamentarier-legen-kranz-in-yad-vashem-nieder/ "Schweizer Parlamentarier legen Kranz in „Yad Vashem“ nieder" Mit einer Kranzniederlegung in der Holocaust-Gedenkstätte „Yad Vashem“ in Jerusalem hat eine Delegation der Parlamentarischen Gruppe Schweiz-Israel am Montag an die 6 Millionen Juden erinnert, die während des 2. Weltkrieges ermordet wurden. Am Dienstag haben die sieben Parlamentarier den Schweizer Verwaltungsratspräsidenten des Aluminuim-Verarbeiters „Extal“, Daniel Basch, in Ma’ale Adumim getroffen, heisst es in einer Mitteilung. Daniel Basch habe den Nationalräten aufgezeigt, dass die internationale politische Situation die Entwicklung des Unternehmens erschwert, schreibt die Gruppe weiter. So tragen Produkte der Firma „Extal“ als Ursprung nicht den Staat Israel, sondern den Namen der Stadt Ma’ale Adumim. Damit müssen die Produkte bei der Einfuhr in die EU und die Schweiz – anders als in den USA – verzollt werden. Diese Mehrkosten trägt die Firma selber. Die arbeitsrechtlichen Bedingungen des Staates Israel würden vollumfänglich für alle Beschäftigten gelten, so Daniel Basch. Gruppenfoto mit dem Verwaltungsratspräsidenten von „Extal“. v.l.n.r) Erich von Siebenthal (SVP), Franz Grüter (SVP), Claudio Zanetti (SVP), Daniel Basch (VR-Präsident „Extal“), Christian Imark (SVP), Alfred Heer (SVP), Sebastian Frehner (SVP), Hans-Ulrich Bigler (FDP). Foto zVg In Gesprächen mit palästinensischen und israelischen Mitarbeitern hätten die Nationalräte den Eindruck gewonnen, dass die Zusammenarbeit dem gegenseitigen Verständnis beider Seiten förderlich sei und das Vertrauen stärke. Bei „Extal“ arbeiten rund 300 Personen, davon rund 180 Mitarbeitende aus dem Westjordanland.  -- Shared with NewsBlur.com

Surgery

[Memic & MST in Israel21c] 7 Israeli robots that are transforming surgery http://blog.ourcrowd.com/memic-in-israel21c-7-israeli-robots-that-are-transforming-surgery/

2000

2,000 year-old seed brought back to life http://www.sizedoesntmatter.com/video/2000-year-old-seed/

Herbal tea

http://www.sizedoesntmatter.com/events/national-tea-day-israel/ "National Tea Day, Spotlight on Israel" By: Abigail Klein Leichman, Israel 21C Herbal tea infusions from Israel’s Galilee region are proving popular with discerning British tea-drinkers  Throwback to 2011, when Israel 21C‘s Abigail Klein Leichman published an article about Israel’s infamous loose-leaf teas (infamous to tea enthusiasts). According to Abigail: “A British distributorship has introduced herbal tea infusions from the Galilee and they’re proving to be a hit with London tea-drinkers. “Our teas are based on dried fruit that gives them a fruity taste, and you can eat the fruit after you finish drinking,” explains Meirav Yaniv, franchise and business development director for The Spicy Way, based in the northern town of Bethlehem-of-the-Galilee in the Jezreel Valley. “It’s apparently very appealing to the English.” Avi Zithershpieler, founder and owner of The Spicy Way, tells ISRAEL21c that it all started with a visit from “two nice ladies from England” to the chain’s Eilat-area location last spring.” Clearly this would be a popular brand, especially with loose-leaf tea growing in popularity (thanks, David’s Tea). Since opening their first store in the UK, The Spicy Way has come up with new blends that sound incredible! Check out the new recipes and shop online, here. For the full article, visit Israel 21 C. -- Shared with NewsBlur.com

Unwatch

http://www.unwatch.org/j-post-cover-interview-hillel-neuer/ "“A Passion For Human Rights”: J. Post Cover Interview of Hillel Neuer" “A Passion For Human Rights” Today’s In Jerusalem magazine of the weekend Jerusalem Post has a cover interview with UN Watch Executive Director Hillel Neuer   JERUSALEM POST: It’s pretty clear to see that Israel is singled out for condemnations and resolutions in the UN. What is behind this? HILLEL NEUER, EXECUTIVE DIRECTOR OF UN WATCH: The UN onslaught against Israel has been entrenched since 1975, when the UN adopted the “Zionism is Racism” resolution. It was repealed, but the infrastructure of anti-Israel resolutions remains. For example, there were 20 resolutions against Israel this year at the General Assembly in New York, compared to only three resolutions against all other countries combined. The campaign against Israel was started by the Arab and Islamic states in the late 1960s. Together, they have 56 votes, and they use them to bring support to their causes: if you vote for them, they vote for you. Terror also helped their cause. In the 70s, when there were Palestinian hijackings, governments like Switzerland went to the PLO and made a deal: if the PLO stopped terrorism, the Swiss would support the Palestinians at the UN in Geneva. And so they did. JERUSALEM POST: In the videos of your speeches, you are so calm and collected despite constant interruptions and accusations by some of the worst regimes in the world. How do you remain so calm and not react to the insanity going on around you? It helps to be Canadian. When I take the floor, I express the full passion that I have for … The post “A Passion For Human Rights”: J. Post Cover Interview of Hillel Neuer appeared first on UN Watch. -- Shared with NewsBlur.com

Melanoma research

http://www.technion.ac.il/en/2016/04/melanoma-mesothelioma-research-with-nyu-lagone/ "Melanoma, Mesothelioma Research with NYU Lagone" Laura and Isaac Perlmutter Cancer Center at NYU Langone and Technion-Israel Institute of Technology Officially Launch Global Cancer Research Initiative Melanoma, Mesothelioma Are the Focus of First Joint Studies Drug-carrying “nanoghosts” that battle melanoma and new treatments for malignant mesothelioma will be the focus of the first joint research projects led by NYU Langone Medical Center and the Technion-Israel Institute of Technology under a groundbreaking research initiative supported by noted philanthropists and NYU Langone Trustees Laura and Isaac Perlmutter. NYU Langone and its Perlmutter Cancer Center – which the Perlmutters named in 2014 with a separate gift of more than $50 million – and the Technion established the new partnership last year to advance global collaboration in cancer research and therapeutics. The joint program is positioned to attract additional, world-class support from institutions and individuals dedicated to eradicating cancer through focused and efficient research. The first $3 million of the Perlmutters’ $9 million donation to the two institutions is earmarked to finance six joint research projects. Co-investigators on each project will receive a two-year, $500,000 grant—$250,000 for each site. The remaining $6 million is designated to establish a state-of-the-art research facility on the Technion campus in Israel to support these and other research projects, primarily in the emerging field of cancer metabolomics, the systematic study of the unique chemical fingerprints that cellular processes leave behind. These processes are both affected by, and can influence, a variety of human diseases, including cancer. Examining a Novel Approach to Treat Metastatic Melanoma In the first joint collaboration, NYU Langone and Technion researchers will test the ability of a nanotechnology based on stem cell “nanoghosts” to deliver to the brain a promising treatment for metastatic melanoma, skin cancer that has spread or metastasized, and is often incurable. In earlier studies, researchers at the Technion took a stem cell, removed its contents, and then shaped a piece of the cell’s outer membrane into a vehicle to deliver treatments into the brain. The idea was to borrow the stem cell’s outer membrane ability to home in on cancer cells. As a fragment of the former stem cell’s membrane, the nanoghost encompasses particular mechanisms that slow it enough to traverse the barrier that filters blood flowing into the brain, and which keeps most drugs from entering. The nanoghost’s cargo is a microRNA (miR), a stretch of genetic material that fine-tunes genetic messages by blocking the conversion of genes into proteins. First applied by NYU researchers to metastatic melanoma, miR-124a, in particular, blocks the expression of cancer-promoting genes. The joint team’s experiments will seek to determine the feasibility of encapsulating miR-124a in the nanoghost, and study how the vehicle reaches its target in mouse models of the disease. “Our studies should provide important information on nanoghosts’ general value as drug and gene carriers to the brain, and create potential for new treatment approaches against brain tumors and metastases,” said Professor Marcelle Machluf, PhD, head of the Laboratory for Cancer Drug Delivery & Cell Based Technologies at the Technion, and inventor of the nanoghost with her colleagues there. “The difficulty of delivering agents to the brain represents a major impediment to improving outcomes in patients suffering from brain tumors. Our state-of-the-art nanovehicle promises safer, simpler and more clinically relevant treatments than existing vehicles, which are comprised of polymers or synthetic vesicles which largely lack the ability to enter the brain and to target evolving and changing pathologies.” “It is much harder to secure funding for this type of high risk, high reward research,” said Eva Hernando-Monge, PhD, associate professor in the Department of Pathology at NYU Langone, a member of the Perlmutter Cancer Center, and leader of the NYU team that first identified miR-124 as a suppressor of the growth of brain metastases. “The Perlmutters’ generous gift gives us the ability to be bold.” Like the stem cells they are based on, nanoghosts are invisible to the immune system, which means they could potentially be made from donated stem cells, expanded to large numbers in the lab, and not just from the patient’s own supply. In the future, this could enable the stockpiling of nanoghost treatments used off the shelf without fear of immune reactions to treatments based on “foreign” cells.  New Approach to Mesothelioma The second joint project will investigate whether an enzyme called heparanase can be used to diagnose and treat mesothelioma, a rare cancer that develops in the mesothelium, the protective lining of the lungs and other internal organs of the body. Malignant pleural mesothelioma (MPM), the most common form of the disease, often occurs after exposure to asbestos and is resistant to most therapies. Heparanase was first identified as a treatment target in 2004 by a team led by Israel Vlodavsky, PhD, one of the project’s co-investigators and professor at the Rappaport Faculty of Medicine. Past studies found that patients with high levels of this enzyme in their tumors have lower survival rates after surgery, and that related tumors in mice respond to treatment with heparanase-inhibiting compounds. The enzyme breaks up molecular chains of heparan sulfate, a building block of the scaffolds that give organs shape and support. Cancer cells use the enzyme to break down tissue barriers around a growing tumor, providing new pathways for the cancer to spread and for the building of blood vessels that supply tumors. In addition, breaking up extracellular matrices releases pro-growth proteins stored there to further drive disease. Furthermore, the joint team has developed the novel theory that heparanase secreted by tumor cells primes local microenvironments in a “vicious” cycle where inflammation and tumor growth drive each other. The co-investigators at NYU Langone — led by Harvey I. Pass, MD, the Stephen E. Banner Professor of Thoracic Surgery and vice chair for research, Department of Cardiothoracic Surgery, at NYU Langone, also a member of its Perlmutter Cancer Center — will use tissue samples from its Thoracic Oncology Archives to validate Dr. Vlodavsky’s findings in hopes of eventually evaluating the treatment potential of heparanase-inhibiting compounds in mesothelioma clinical trials. Dr. Pass has been collecting tissue samples from his surgical patients since 1989, when he was head of thoracic oncology at the National Cancer Institute (NCI). The collection now houses frozen specimens from more than 350 mesothelioma patients. “This project, supported through the generosity of the Perlmutters, enables us to collaborate with one of the world’s leading experts on the role of heparanase in cancer, and is crucial in developing new strategies,” Dr. Pass says. “We hope that these experiments can be translated into applications for ongoing funding from the NCI, and enable Phase I trials with new therapeutics that influence heparanase pathways.” “Our collaboration represents the first attempt to focus on heparanase as a major risk factor in mesothelioma and a valid target for the development of heparanase-inhibiting drugs,” Dr. Vlodavsky says. “In fact, applying a potent inhibitor of the heparanase enzyme we have already demonstrated a most prominent inhibition of tumor progression in mouse models of human mesothelioma, resulting in a pronounced extension of mouse survival. This joint effort provides an opportunity to make important strides in both our fundamental understanding of mesothelioma and in translating this knowledge into therapeutics.” -- Shared with NewsBlur.com

MBA

MIT Sloan School matches MBA students with Israeli start-ups in new Israel Lab program http://www.jpost.com/Israel-News/MIT-Sloan-School-matches-MBA-students-with-Israeli-start-ups-in-new-Israel-Lab-program-445849

NGO

Nichtregierungsorganisationen - Waffen im Krieg gegen Israel - Audiatur-Online http://www.audiatur-online.ch/2016/02/16/nichtregierungsorganisationen-waffen-im-krieg-gegen-israel/ Shared from PeanutBrowser.com.

Moon 10

10 Simple Questions for Ban Ki-moon as he visits Canada http://www.unwatch.org/10-questions-for-ban-ki-moon-as-he-visits-canada/

UN

Top 10 Worst U.N. Moments of 2015 - UN Watch http://www.unwatch.org/uns-top-10-worst-decisions-2015/ Shared from PeanutBrowser.com.

Base ball

Baseball-Programm erzielt Homerun für Freundschaft - Audiatur-Online http://www.audiatur-online.ch/2016/02/10/baseball-programm-erzielt-homerun-fuer-freundschaft/ Shared from PeanutBrowser.com.

DNA

Genomic Eclipse http://www.technion.ac.il/en/2016/02/genomic-eclipse/

Slantnews

Globes English - Startup Slant lets users earn money for content http://www.globes.co.il/en/article-new-startup-lets-users-write-news-content-earn-money-1001047556 Shared from PeanutBrowser.com.

Oxford

Oxford University Press signs deal with 3 Israeli start-ups http://www.timesofisrael.com/oxford-university-press-signs-deal-with-3-israeli-start-ups/

Website

Building a Visual Brand for Your Website http://www.weebly.com/blog/building-a-visual-brand

Moon

Ban Ki-moon - Eine billige Profilierung auf Kosten Israels - Audiatur-Online http://www.audiatur-online.ch/2016/02/03/ban-ki-moon-eine-billige-profilierung-auf-kosten-israels/ Shared from PeanutBrowser.com.

Völker Recht

Völkerrecht anerkennt jüdische Ansprüche in Judäa und Samaria http://www.audiatur-online.ch/2016/02/03/voelkerrecht-erkennt-juedische-ansprueche-in-judaea-und-samaria-an/

Tanz

Video: Tanz über den Wolken - Israel Heute http://www.israelheute.com/Nachrichten/Artikel/tabid/179/nid/29634/Default.aspx Shared from PeanutBrowser.com.

Internationale

Israelische Siedlungen und das internationale Recht - Israel Heute http://www.israelheute.com/Nachrichten/Artikel/tabid/179/nid/29631/Default.aspx Shared from PeanutBrowser.com.

Aging

Israeli scientist seeks cure for aging http://www.sizedoesntmatter.com/science/cure-for-aging/

Made in Jerusalem

Entrepreneurs, Investors to Convene in Jerusalem for Major Global High-Tech Summit | Jewish & Israel News Algemeiner.com http://www.algemeiner.com/2016/01/24/entrepreneurs-investors-to-convene-in-jerusalem-for-major-global-high-tech-summit/# Shared from PeanutBrowser.com.

Nzz

Eine fatale Ausgrenzung von Fakten - Audiatur-Online http://www.audiatur-online.ch/2016/01/26/eine-fatale-ausgrenzung-von-fakten/ Shared from PeanutBrowser.com.

Flavours

VIDEO: Bringing Together Ancient Israeli Flavours http://www.sizedoesntmatter.com/video/ancient-israeli-flavours/

Wee

Sur Zeit's Blog - Blog http://surzeit.weebly.com/ Shared from PeanutBrowser.com.

Smart

Globes English - Global automakers look to Israeli smart car startups http://www.globes.co.il/en/article-global-automakers-look-to-israeli-smart-vehicle-startups-1001096714 Shared from PeanutBrowser.com.

Of bigs

Internet of Things: The next big thing in Israeli tech [Infographic] - OurCrowd http://blog.ourcrowd.com/index.php/2016/01/04/internet-of-things-the-next-big-thing-in-israeli-tech-infographic/ Shared from PeanutBrowser.com.

Of things

Internet Of Things Is The Next Big Thing In Israeli Tech -- Here's Why - Forbes http://www.forbes.com/sites/eyalbino/2016/01/03/internet-of-things-is-the-next-big-thing-in-israeli-tech-heres-why/#2715e4857a0b47b004e36a8a Shared from PeanutBrowser.com.

Westeuropas

Westsahara: Europas Fischzug, Wallströms Wahn http://www.audiatur-online.ch/2016/01/20/westsahara-europas-fischzug-wallstroems-wahn/

Emotional

Can the tone of a message change your emotional state? http://www.sizedoesntmatter.com/science/change-emotional-state/

IFit

Israeli ‘sleepables’ to boost performance of iFit’s fitness tech http://www.timesofisrael.com/israeli-sleepables-to-boost-performance-of-ifits-fitness-tech/

Negev

Video: Entspannte Negev Wüste - Israel Heute http://www.israelheute.com/Nachrichten/Artikel/tabid/179/nid/29592/Default.aspx Shared from PeanutBrowser.com.

Coursera

Nanotechnology and Nanosensors - Technion - Israel Institute of Technology | Coursera https://www.coursera.org/course/nanosensors Shared from PeanutBrowser.com.

Eu

BDS-Förderer und EU-Regierungen finanzieren B´Tselem - Israel Heute http://www.israelheute.com/Nachrichten/Artikel/tabid/179/nid/29578/Default.aspx Shared from PeanutBrowser.com.

Upa

Palestine Group Here Backs Upa Campaign | Jewish Telegraphic Agency http://www.jta.org/1941/01/13/archive/palestine-group-here-backs-upa-campaign Shared from PeanutBrowser.com.

Associated what?

Die Semantik von Associated Press – eine einfache Taktik für antiisraelische Einseitigkeit - Audiatur-Online http://www.audiatur-online.ch/2016/01/12/die-semantik-von-associated-press-eine-einfache-taktik-fuer-antiisraelische-einseitigkeit/ Shared from PeanutBrowser.com.

Processed food

The Jerusalem Post http://m.jpost.com/Business-and-Innovation/Health-and-Science/Israeli-German-researchers-find-link-between-industrialized-foods-and-autoimmune-diseases-439296#article=10389Q0M2QkZFOUY5RDE0REI4REZCOEU3QjA2MUUzODVGNjY= Shared from PeanutBrowser.com.

Französische Startups in Tel Aviv

Französische Startups in Tel Aviv